IP Library Granted Patent US 10,011,849
Granted Patent B1
US 10,011,849 · App. 15/631,989 · Granted Jul 3, 2018

Nucleic acid-guided nucleases

Inventors: Ryan T. Gill (Denver, CO); Andrew Garst (Boulder, CO); Tanya Elizabeth Warnecke Lipscomb (Boulder, CO)
Assignee: Inscripta, Inc.
C12N15/902C12N9/22C12N15/11C12N15/70C12N15/81C12N15/85C12N15/905C12N15/907C12N2310/20C12N2800/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,011,849
App. No.
15/631,989
Granted
Jul 3, 2018
Kind
B1
Abstract

Disclosed herein are nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems, and methods of use. Disclosed herein are engineered non-naturally occurring nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems, and methods of use. Targetable nuclease systems can be used to edit genetic targets, including recursive genetic engineering and trackable genetic engineering methods.

Claims (10)

1. A nucleic acid-guided nuclease system comprising:

(a) a nucleic acid having at least 95% identity to SEQ ID NO: 22, SEQ ID NO: 42, SEQ ID NO: 128, or SEQ ID NO: 148, wherein the nucleic acid encodes a nucleic acid-guided nucleases comprising the amino acid sequence of SEQ ID NO:2;

(b) an engineered guide nucleic acid capable of complexing with the nucleic acid-guided nuclease, wherein the engineered guide nucleic acid comprises any one of SEQ ID NO: 88, SEQ ID NO: 93, and SEQ ID NO: 94 and

(c) an editing sequence having a change in sequence relative to the sequence of a target region in a genome of a cell and a mutation in a protospacer adjacent motif (PAM);

wherein the system results in a genome edit in the target region in the genome of the cell facilitated by the nuclease, the engineered guide nucleic acid, and the editing sequence.

2. The system of claim 1 , wherein the engineered guide nucleic acid and the editing sequence are provided as a single nucleic acid.

3. The system of claim 1 , wherein the nucleic acid encoding for the nucleic acid-guided nuclease is codon optimized for E. coli.

4. The system of claim 1 , wherein the nucleic acid encoding for the nucleic acid-guided nuclease is codon optimized for S. cerevisiae.

5. The system of claim 1 , wherein the nucleic acid encoding for the nucleic acid-guided nuclease is codon optimized for mammalian cells.

6. The system of claim 1 , wherein the nucleic acid-guided nuclease has less than 40% protein identity to SEQ ID NO: 12 and SEQ ID NO: 108.

Assignments (3)
MERGER AND CHANGE OF NAME Recorded Sep 15, 2025
From: INSCRIPTA, INC.,; MANUS INSCRIPTA, INC.
To: MANUS INSCRIPTA, INC.
Reel/Frame 072252/0203 →
CHANGE OF NAME Recorded Jan 29, 2018
From: MUSE BIOTECHNOLOGY, INC.
To: INSCRIPTA, INC.
Reel/Frame 045071/0755 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2017
From: GILL, RYAN T.; GARST, ANDREW; LIPSCOMB, TANYA ELIZABETH WARNECKE
To: MUSE BIOTECHNOLOGY, INC.
Reel/Frame 043633/0860 →
Cited By (8)
US 12,195,749 US 12,270,044 US 12,319,932 US 12,410,449 US 12,435,323 US 12,529,076 US 12,649,921 US 12,692,487